MetLife Investment Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,572
| Closed | -$122K | – | 2851 |
|
|
2023
Q3 | $122K | Hold |
2,572
| – | – | ﹤0.01% | 2476 |
|
|
2023
Q2 | $246K | Buy |
2,572
+691
| +37% | +$66.2K | ﹤0.01% | 2147 |
|
|
2023
Q1 | $213K | Buy |
1,881
+284
| +18% | +$32.2K | ﹤0.01% | 2184 |
|
|
2022
Q4 | $179K | Sell |
1,597
-332
| -17% | -$37.2K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $248K | Buy |
1,929
+1,338
| +226% | +$172K | ﹤0.01% | 2148 |
|
|
2022
Q2 | $40.6K | Sell |
591
-1,396
| -70% | -$95.8K | ﹤0.01% | 2816 |
|
|
2022
Q1 | $283K | Buy |
1,987
+710
| +56% | +$101K | ﹤0.01% | 2127 |
|
|
2021
Q4 | $213K | Buy |
1,277
+634
| +99% | +$106K | ﹤0.01% | 2018 |
|
|
2021
Q3 | $89.5K | Sell |
643
-630
| -49% | -$87.7K | ﹤0.01% | 2483 |
|
|
2021
Q2 | $607K | Buy |
1,273
+191
| +18% | +$91.1K | 0.01% | 1454 |
|
|
2021
Q1 | $446K | Sell |
1,082
-57
| -5% | -$23.5K | ﹤0.01% | 1594 |
|
|
2020
Q4 | $558K | Hold |
1,139
| – | – | 0.01% | 1433 |
|
|
2020
Q3 | $645K | Sell |
1,139
-1
| -0.1% | -$566 | 0.01% | 1240 |
|
|
2020
Q2 | $109K | Buy |
+1,140
| New | +$109K | ﹤0.01% | 2218 |
|